Global COVID-19 Vaccines Development and Rollout Report 2021: Mass Rollouts Begin but Hurdles are Halting Progress – ResearchAndMarkets.com – Business…

DUBLIN--(BUSINESS WIRE)--The "COVID-19 Vaccines - Mass Rollouts begin but Hurdles are Halting Progress" report has been added to ResearchAndMarkets.com's offering.

2021 has started tougher than many expected, with new variants causing a surge in cases and health systems once again overwhelmed globally.

This has prevented economic recovery which seemed to be on the mend in the summer when infection rates had fallen. Global economic growth is still expected to rebound quickly but this is unlikely to be as high as previously estimated, the World Bank has already reduced its forecast to 4% for 2021.

Despite this, the rapid creation of vaccines has offered hope and a way out of the crisis is now visible.

Key Figures

Key Highlights

Scope

Reasons to Buy

Key Topics Covered:

1. OVERVIEW

1.1. Catalyst

1.2. Summary

2. GLOBAL CASES SURGING BUT VACCINE DEVELOPMENT HAS PROVIDED OPTIMISM

2.1. Quick development of vaccines has been a significant scientific feat

2.1.1. Wide range of vaccinology uses has helped the creation of a large number of vaccines

2.1.2. Early release of genome data crucial in early development of vaccines

3. HICCUPS HAVE ALREADY PLAGUED PLANNED VACCINE ROLLOUTS IN MULTIPLE REGIONS

3.1. Delays to regulatory approval and supply issues have disrupted EU vaccine plans

3.1.1. EU and AstraZeneca lock horns over supply issue

3.2. Poor governance has hindered vaccine rollout and procurement

3.2.1. Joe Biden looks to implement an effective vaccination plan after Trump chaos

3.3. Public skepticism of vaccines could reduce uptake.

3.3.1. Hesitancy has links with populism

3.3.2. Public mistrust of authority is rife across the globe

4. COVAX INITIATIVE SET UP TO PROVIDE LOW AND MIDDLE INCOME COUNTRIES ACCESS TO VACCINE

4.1. Oxford-AstraZeneca vaccine to play primary role for COVAX

4.2. Domestic supply remains the priority for countries

4.2.1. WHO warns of a 'catastrophic moral failure'

4.3. Vaccine procurement mirrors worrying pandemic trend

5. ALTERNATIVE VACCINES NOW VIEWED AS AN OPTION DUE TO CURRENT SHORTAGES

5.1. Vaccine provides soft power opportunity for China and Russia

5.1.1. Deals with Chinese and Russian vaccine makers are helping boost vaccine supply

5.1.2. Argentina quick to rollout Sputnik V

6. APPENDIX

6.1. Abbreviations and acronyms

6.2. Sources

6.3. Further reading

7. ASK THE ANALYST

For more information about this report visit https://www.researchandmarkets.com/r/ptl8ms

Read this article:

Global COVID-19 Vaccines Development and Rollout Report 2021: Mass Rollouts Begin but Hurdles are Halting Progress - ResearchAndMarkets.com - Business...